Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER_GOV × Liver Neoplasms × toripalimab × Clear all

Phase

Status

Sponsor Class

OTHER 3 INDUSTRY 2 OTHER_GOV 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Triple Negative Breast Neoplasms 1 Nasopharyngeal Carcinoma 1 Liver Neoplasms 1 Esophageal Squamous Cell Carcinoma 1 EGFR Positive Non-small Cell Lung Cancer 1 Chemotherapy 1 Carcinoma, Non-Small-Cell Lung 1

Interventions

toripalimab 1 lenvatinib 1 Sorafenib 1 Radiofrequency Ablation 1 Proton Therapy 1 Population Groups 1 Antineoplastic Agents 1 Anesthesia, General 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05162898 2022-01-27

Radiofrequency Ablation Combined With Toripalimab and Lenvatinib in the Treatment of Short-term Recurrent Hepatocellular Carcinoma.

Henan Cancer Hospital

Phase NA Unknown

Gastrointestinal

Liver Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡